bpc 157 detection window doping BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers Big FDA review coming this
Description
Scott Butsch, W
Your results suffer, and you blame the peptide when the real problem was measurement error during reconstitution

I was still lightheaded and nauseated

On a semi-log plot the two phases are approximately linear, with slopes and , and corresponding half-lives t 1/2 = 0.693/ and t 1/2 = 0.693/